Jounce Therapeutics, Inc (JNCE) insider trading

Every open-market stock purchase and sale by Jounce Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Kevin C Tang (10% owner), $20.7K, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent JNCE insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at Jounce Therapeutics, Inc files a new trade →